AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02392429 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fluorothymidine F-18
Description: Undergo FLT PET/CT
Study NCT02392429 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02392429 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo FLT PET/CT
Study NCT04746690 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Slider, tensioner neurodynamic mobilization techniques and stretching exercises of back, hamstrings and gastrocnemius
Description: neurodynamic mobilization techniques of sciatic nerve and stretching exercises of back extensors, hamstrings and lower limbs for patients with chronic discogenic sciatica.
Study NCT03685253 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules matched to the experimental drug and taken orally as 2 capsules twice daily for 6 months.
Study NCT01601119 — intervention group
Intervention type: DRUG
Intervention: Rebif
Description: The subjects will receive Rebif as per the current practices or as directed by the physician.
Study NCT01601119 — intervention group
Intervention type: OTHER
Intervention: Other: Disease modifying therapies (DMT)
Description: The subjects will receive other DMTs as per the current practices or as directed by the physician.
Study NCT03622060 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nitroglycerin
Description: 200 microgram intraarterial nicardipine and 500 microgram nitroglycerin administered before sheath removal
Study NCT03622060 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitroglycerin
Description: 200 microgram intraarterial nicardipine and 500 microgram nitroglycerin administered before sheath removal
Study NCT03481868 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Collection of blood and bone marrow
Description: Collection of blood and bone marrow in order to identify epigenetic abnormalities and their consequences in surviving CML cells after 3 months of TKI treatment
Study NCT01808599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chlorambucil
Study NCT01808599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab i.v.
Study NCT01808599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab s.c.
Study NCT00435708 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 5 portions fruit and vegetables/day
Description: Participants consume > = 5 portions fruit and veg per day
Study NCT04521179 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KN026 combination
Description: 30 mg/kg Q3W KN026+ 5 mg/kg Q3W KN046
Study NCT04358185 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itacitinib (INCB039110)
Description: Novel and small molecule selective inhibitor of JAK1
Study NCT04628390 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser
Description: The laser application will be carried out only once, immediately after the cementation of the orthodontic appliance.
Study NCT04628390 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Simulation laser application will be carried out only once, immediately after the cementation of the orthodontic appliance.
Study NCT04537234 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: High-Dose Quadrivalent Influenza Vaccine
Description: Pharmaceutical form: Suspension for injection in pre-filled syringe,~Route of administration: IM
Study NCT04537234 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard-Dose Quadrivalent Influenza Vaccine
Description: Pharmaceutical form: Suspension for injection in pre-filled syringe,~Route of administration: IM
Study NCT01304511 — intervention group
Intervention type: DRUG
Intervention: Orgalutran
Study NCT04483791 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: OTHER
Intervention: DynamX Novolimus Eluting Coronary Bioadaptor System
Description: up to two de novo native coronary artery lesions measuring between 2.25 and 3.5 mm in diameter and\<=34 mm in length receiving the DynamX Novolimus Eluting Coronary Bioadaptor System
Study NCT01503515 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Caspofungin Acetate
Description: Given IV
Study NCT01503515 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluconazole
Description: Given IV or PO
Study NCT01503515 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Optional correlative studies
Study NCT03741608 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home blood pressure measurement
Description: Participants will be taught to use an automated blood pressure cuff and will be asked to provide monthly blood pressure readings to study staff.
Study NCT05639387 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: actual tVNS
Description: Active tVNS (stimulation on cymba conchae --> nervus vagus stimulation)
Study NCT05639387 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: sham tVNS
Description: Sham tVNS (stimulation on earlobe --> no nervus vagus stimulation)
Study NCT04039581 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesio Taping
Description: Kinesio Taping relaxation technique (muscle inhibition technique)
Study NCT04039581 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesio Taping
Description: Kinesio Taping relaxation technique (muscle inhibition technique)
Study NCT04039581 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional treatment
Description: Therapeutic exercises (active and passive range of motion (ROM) and strengthening exercise ) and TENS (Transcutaneous electrical nerve stimulation) applications
Study NCT04039581 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment
Description: Therapeutic exercises (active and passive range of motion (ROM) and strengthening exercise ) and TENS (Transcutaneous electrical nerve stimulation) applications
Study NCT03539315 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ARCHES
Description: Addressing Reproductive Coercion within Healthcare Settings (ARCHES) is a clinic-based intervention developed in the U.S., and involves training existing health providers to identify RC and IPV during standard family planning clinic-based counselling interactions. The intervention seeks to empower women with harm reduction strategies that minimize their risk for unintended pregnancy by offering a wide range of contraceptive options, providing counseling on correct and consistent use of contraception, and counseling on contraceptive methods that are difficult for a male partner to detect or block such as injectables or IUDs. ARCHES also facilitates access to violence support and counselling services by connecting women with community-based IPV services.
Study NCT00922454 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endovascular Repair of the abdominal aorta
Description: Patients will undergo or have undergone endovascular aneurysm repair which is minimally invasive approach using endoluminal placement of a stent graft.~EVAR, CTA imaging, 1, 6 12 months post treatment.
Study NCT00922454 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cook Zenith Stent-Graft
Description: Cook Zenith AAA Endovascular Graft
Study NCT00922454 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Talent Stent-Graft
Description: Talent AAA Abdominal Stent Graft System
Study NCT04166357 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: neuromuscular ultrasound
Description: Neuromuscular ultrasound refers to a field in medicine in which ultrasound is used to diagnosis and guide treatment for people with neuromuscular diseases. Neuromuscular ultrasound is often combined with electrodiagnosis, and particularly nerve conduction studies and EMG, to improve the accuracy of diagnosis and add anatomic information to the functional information obtained with electrodiagnosis. It has been demonstrated that neuromuscular ultrasound adds value to the diagnosis of nerve disease in over 80% of cases.
Study NCT06390839 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy
Study NCT06390839 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06390839 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT06390839 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT06390839 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Palbociclib
Description: Given PO
Study NCT03194802 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleeping Without Pills Program
Description: Participants receive this program online and are asked to log in daily for 6 weeks.
Study NCT03194802 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-monitoring
Description: Participants enter sleep diary data online daily for 6 weeks
Study NCT00517738 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical training
Description: A program of exercising under strict surveillance, with endurance and coordination maneuvers
Study NCT00517738 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diet intervention
Description: Energy intake tailored to basal metabolism and level of physical activity. Protein and sodium intake will be adjusted to 1.2-1.5 g/kg/d, and 1.5-2 g/d of salt, respectively. The latter will be adjusted only in those patients presenting ascites and/or edema
Study NCT00517738 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diet intervention
Description: Energy intake tailored to basal metabolism and level of physical activity. Protein and sodium intake will be adjusted to 1.2-1.5 g/kg/d, and 1.5-2 g/d of salt, respectively. The latter will be adjusted only in those patients presenting ascites and/or edema
Study NCT01921673 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dovitinib and docetaxel
Description: In phase I portion of the study Docetaxel 45-75 mg/m2, intravenous, every 3 weeks Dovitinib 200-500 mg, oral, 5 days on/2 days off~In phase II portion of the study Recommended dose of docetaxel and dovitinib in phase I portion will be used.
Study NCT01792063 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Study NCT02868359 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: The study is observational.
Study NCT00533377 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CP-533, 536
Description: Active study drug
Study NCT00533377 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo vehicle
Study NCT00533377 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Standard of Care
Description: Standard surgical procedure
Study NCT00533377 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CP-533,536
Description: Active study drug
Study NCT00410722 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Whole wheat and bran muffin
Study NCT01952535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HMS5552
Study NCT01952535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study NCT04954118 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Internal jugular vein cannulation
Description: The clinicians performed an internal jugular vein cannulation using personal protective equipment (PPE) or both of the aerosol box and PPE provide insertion of a central venous catheter in COVID-19 patients.
Study NCT03658174 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Nitrate-rich beetroot juice
Description: 70mls of concentrated beetroot juice containing approximately 5-6 mmol of inorganic nitrate
Study NCT03658174 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Nitrate-free beetroot juice
Description: 70mls of concentrated beetroot juice that has been nitrate-depleted
Study NCT04171999 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Community Rx-Hunger (CRx-H)
Description: The CRx-H Intervention provides dosages of health content that offer assistance for food insecurity and other health-related social needs. A caregiver randomized to the intervention will receive a hard-copy print-out of their tailored list of resources to address food insecurity. A member of our research team will deliver this list and provide a brief educational component which includes: a brief, structured script about the common problem of food insecurity in households with children and co-occuring HRSNs, review of the resource list which includes nearby, vetted resources to address these needs and coaching on how to activate resources on the list. Prior to discharge, the caregiver will receive a duplicate copy of the list of resources. After discharge, the caregiver will receive text messages at a frequency based on the Critical Time Intervention (CTI) Model, from baseline to 3 months post discharge, in order to receive ongoing support by a research team member.
Study NCT00410722 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whole wheat and bran muffin
Study NCT00410722 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Mixed tree nuts
Study NCT03776630 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Blood sample
Description: Two blood samples (2 tubes of 4 ml for each blood sample) will be collected per patient during the study period for EC and OC. One blood sample will be collected for control population. The first sample will be collected prior to any treatment for EC, OC, and control population.~For EC, the second collection will be done one month post-surgery. For OC, the second collection will be done 6 to 9 months after the initial diagnosis, in most cases at the completion of adjuvant chemotherapy. For control population, there will be no second sample.
Study NCT01869322 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sling and Swathe
Description: Sling and Swathe immobilization of humeral shaft fracture.
Study NCT01869322 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Coaptation Splint
Description: Coaptation splint immobilization of humeral shaft fractures.
Study NCT01623310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone Propionate
Description: Using Optinose Exhalation Delivery System
Study NCT04417790 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Lung ultrasound and EVLW measurement by transpulmonary thermodilution.
Description: Lung ultrasonography by 8 Quadrant protocol of Volpicelli et al. Transpulmonary thermodilution for extravascular lung water measurement
Study NCT02099461 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Denosumab
Description: Single sucutaneous dose
Study NCT01503515 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Laboratory Biomarker Analysis
Description: Optional correlative studies
Study NCT01503515 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Voriconazole
Description: Given IV or PO
Study NCT02762500 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LYC-30937-EC
Study NCT02762500 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT01350102 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bacitracin
Description: Participants will be treated with Bacitracin to their wound until 100% wound healing, which may take up to 6 months to achieve.
Study NCT01350102 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AmeriGel®
Description: Participants will be treated with AmeriGel® to their wound until 100% wound healing, which may take up to 6 months to achieve.
Study NCT01350102 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin C
Description: Participants will be treated with Vitamin C supplements 1000 mg daily until 100% wound healing, which may take up to 6 months to achieve
Study NCT01985945 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Yoga
Study NCT01275872 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Guided Imagery and Progressive Muscle Relaxation
Description: 4 supervised sessions per patient for 4 weeks additional to daily unsupervised sessions
Study NCT00003934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tretinoin
Description: Given orally
Study NCT00003934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: daunorubicin hydrochloride
Description: Given IV
Study NCT00003934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytarabine
Description: Given IV
Study NCT02099461 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous core needle breast biopsy
Study NCT00003934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mercaptopurine
Description: Given IV
Study NCT02099461 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Percutaneous core needle breast biopsy
Study NCT00956228 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radioimmuniguided intenstiy modulated radiotherapy
Description: All patients recieved 75.6 Gy in 42 fractions to the prostate and the region of the prostate which enhanced on prostascint scan was simaltaneously boosted to a total dose of 82 Gy
Study NCT00003934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methotrexate
Description: Given IV
Study NCT00003934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: arsenic trioxide
Description: Given IV
Study NCT02211508 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RINCE
Description: The NeuroPoint device is used to deliver repeat applications of RINCE therapy
Study NCT02211508 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: RINCE
Description: The NeuroPoint device is used to deliver repeat applications of RINCE therapy
Study NCT04945356 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: upper limb training
Description: The 6-week exercise program will consist of evidence-based exercises covering the breadth and depth of rehabilitation interventions. The therapist will choose the appropriate exercises for each participant's level of function from more than 15,000 exercises implemented within the Physiotec app and developed by rehabilitation experts. Personalized upper limb exercises will be based on the therapist initial assessment of participants, using the TERA+ telerehabilitation platform, and their goals. After each training session, participants will have to rate their perceived level of effort on a Borg scale (/10). The Borg scores will be monitored by the therapist as a precautionary measure to ensure safety and appropriateness of intensity of exercises. Participants will be instructed to train at a target score of around 7/10 (somewhat hard) on the Borg scale.
Study NCT02721628 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Epi-keratoplasty
Description: Femtosecond laser assisted Epi-keratoplasty
Study NCT02721628 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Collagen Cross-Linking
Description: Collagen Cross-Linking: Standard procedure, which is descriptor bellows: Corneal epithelium is mechanically removed. Then, a solution of riboflavin is instilled each minute for 30 minutes. Corneas are irradiated by a UVA light for 3mW/cm2 during 30 minutes
Study NCT02721628 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Femtosecond laser
Description: Use in the epic-keratoplasty surgery
Study NCT00717925 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inotuzumab Ozogamicin (CMC-544)
Description: Intravenous (IV) infusion, 1.3 - 1.8 mg/m2, every 28 days, 4 cycles
Study NCT00527371 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GreenLight HPS (TM)laser system [Photoselective Vaporization of the prostate (PVP)]
Description: Photoselective vaporization of the prostate will be performed using the GreenLight HPS (TM)laser system (American Medical Systems), which is a high-power (120W) potassium titanyl phosphate (KTP) laser which was licensed by Health Canada in April 2007.
Study NCT00527371 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transurethral resection of the prostate
Description: Transurethral resection of the prostate will be performed with a continuous flow resectoscope and unipolar cautery using a standard technique.
Study NCT02061215 — intervention group
Intervention type: OTHER
Intervention: CMV viral load
Study NCT01578278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bepotastine besilate formulation
Description: Nasal Spray
Study NCT01578278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Description: Nasal Spray
Study NCT01578278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bepotastine besilate-fluticasone propionate
Description: Nasal Spray
Study NCT01578278 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: Nasal Spray